3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
3
Phase 2
2
Phase 1
2
Phase NA
1
Status
Completed
35
Active not recruiting
14
Terminated
10
Withdrawn
3
Recruiting
3
Not yet recruiting
2
Unknown
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Carcinoma, Non-Small-Cell Lung
134
Breast Neoplasms
94
Colorectal Neoplasms
65
Carcinoma, Hepatocellular
57
Squamous Cell Carcinoma of Head and Neck
48
Stomach Neoplasms
46
Lung Neoplasms
45
Triple Negative Breast Neoplasms
43
Prostatic Neoplasms
43
Leukemia, Myeloid, Acute
43
Small Cell Lung Carcinoma
41
Uterine Cervical Neoplasms
40
Rectal Neoplasms
37
Neoplasms
31
Pancreatic Neoplasms
30
Recurrence
29
Neoplasm Metastasis
29
Esophageal Squamous Cell Carcinoma
25
Esophageal Neoplasms
24
Ovarian Neoplasms
23
Nasopharyngeal Carcinoma
21
Brain Neoplasms
21
Melanoma
20
Lymphoma, Large B-Cell, Diffuse
20
Colonic Neoplasms
20
Carcinoma, Renal Cell
20
Head and Neck Neoplasms
19
Endometrial Neoplasms
19
Multiple Myeloma
18
Biliary Tract Neoplasms
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Not yet recruiting
×
Ependymoma
×
Clear all
NCT06804655
2026-05-06
EViDENCE-BT
University of Zurich
Phase 2
Not yet recruiting
40 enrolled
NCT06678867
2025-03-27
P5A
University College, London
Phase 2
Not yet recruiting
80 enrolled